Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for 511243

Update shared on 22 Oct 2025

Fair value Increased 0.15%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
36.8%
7D
-3.1%

Cholamandalam Investment and Finance's analyst price target has risen slightly from ₹1,597.36 to ₹1,599.79. Analysts cite marginal improvements in forecasted revenue growth, profit margins, and valuation metrics, which support a modestly higher fair value estimate.

What's in the News

  • A board meeting is scheduled for November 6, 2025. The meeting will review and approve the audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025 (Company announcement).

Valuation Changes

  • Consensus Analyst Price Target has risen slightly from ₹1,597.36 to ₹1,599.79.
  • Discount rate has edged up from 16.57% to 16.58%.
  • Revenue growth expectation increased moderately from 31.50% to 31.51%.
  • Net profit margin is projected to improve from 32.90% to 32.94%.
  • Future P/E ratio remains largely unchanged, moving from 25.10x to 25.11x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.